Abstract
BackgroundThere is a need for biomarkers that can predict anti-tumour necrosis factor (anti-TNF) treatment outcome in patients with rheumatoid arthritis (RA). Several studies have suggested that the rare A allele...
Paper version not known
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have